Carnegie Investment Counsel Boosts Position in Mettler-Toledo International Inc. (NYSE:MTD)

Carnegie Investment Counsel grew its position in Mettler-Toledo International Inc. (NYSE:MTD) by 1.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,256 shares of the medical instruments supplier’s stock after buying an additional 205 shares during the quarter. Carnegie Investment Counsel owned 0.07% of Mettler-Toledo International worth $17,444,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Blue Trust Inc. grew its stake in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 17 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of Mettler-Toledo International in the third quarter valued at about $37,000. Itau Unibanco Holding S.A. acquired a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $42,000. Raleigh Capital Management Inc. increased its stake in shares of Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 30 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. raised its position in shares of Mettler-Toledo International by 60.0% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Robert W. Baird dropped their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wells Fargo & Company cut their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price objective for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,297.98 on Friday. The company has a market cap of $27.39 billion, a P/E ratio of 35.00, a P/E/G ratio of 3.83 and a beta of 1.12. Mettler-Toledo International Inc. has a 12 month low of $1,133.46 and a 12 month high of $1,546.93. The company has a 50-day moving average of $1,244.08 and a 200-day moving average of $1,344.96.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, equities research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.